N-benzoxazol-2-yl-N′-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential Johann HofmannJohnny EasmonGiuseppe Musumarra PRECLINICAL STUDIES 09 July 2008 Pages: 189 - 202
Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis Selvaraj AranganathanJayabal Panneer SelvamNamasivayam Nalini PRECLINICAL STUDIES 22 July 2008 Pages: 203 - 213
Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in mice Sattu KamarajGopalakrishnan RamakrishnanThiruvengadam Devaki PRECLINICAL STUDIES 13 August 2008 Pages: 214 - 222
Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines Xishan XiongYangliang YeChanglin Mei PRECLINICAL STUDIES 13 August 2008 Pages: 223 - 232
Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis Gopalakrishnan RamakrishnanSundaram JaganThiruvengadam Devaki Preclinical Studies 30 July 2008 Pages: 233 - 240
Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin) Masaaki OuchiHitoshi KawamuraToshiyoshi Fujiwara PRECLINICAL STUDIES 27 August 2008 Pages: 241 - 245
Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells G. Harish KumarK.V.P. Chandra MohanS. Nagini PRECLINICAL STUDIES 22 August 2008 Pages: 246 - 252
Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer Michael MichaelPeter GibbsNiall Tebbutt PHASE I STUDIES 11 November 2008 Pages: 253 - 261
Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients Lisardo UgidosSalvadora DelgadoJoan Maurel PHASE I STUDIES 16 October 2008 Pages: 262 - 268
A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer Sun Young KimYong Sang HongKyung Hae Jung PHASE II STUDIES 25 September 2008 Pages: 269 - 274
A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer Bryan H. BurmeisterEuan T. WalpoleB. Mark Smithers PHASE II STUDIES 08 October 2008 Pages: 275 - 279
Enhancement of the action of the antivascular drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA; ASA404) by non-steroidal anti-inflammatory drugs L.-C. Steve WangLai-Ming ChingBruce C. Baguley Short Report 12 August 2008 Pages: 280 - 284
Rhinitis and epistaxis in patients treated by anti-angiogenic therapy V. Prulière-EscabasseE. EscudierC. Massard SHORT REPORT 27 August 2008 Pages: 285 - 286
Publication biases and phase II trials investigating anticancer targeted therapies Nicolas PenelAntoine Adenis SHORT REPORT 18 October 2008 Pages: 287 - 288